Pro Medicus Limited (ASX: PME)
Australia
· Delayed Price · Currency is AUD | Market Cap | 14.24B |
| Revenue (ttm) | 142.12M |
| Net Income (ttm) | 69.71M |
| Shares Out | 104.43M |
| EPS (ttm) | 0.67 |
| PE Ratio | 206.20 |
| Forward PE | 113.64 |
| Dividend | 0.35 (0.26%) |
| Ex-Dividend Date | Feb 29, 2024 |
| Volume | 333,588 |
| Open | 135.73 |
| Previous Close | 136.09 |
| Day's Range | n/a |
| 52-Week Range | 61.95 - 144.34 |
| Beta | 0.51 |
| Analysts | n/a |
| Price Target | 105.75 (-22.46%) |
| Earnings Date | Aug 13, 2024 |
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and cli... [Read more]
Financial Performance
In 2023, Pro Medicus's revenue was 124.90 million, an increase of 33.64% compared to the previous year's 93.46 million. Earnings were 60.65 million, an increase of 36.47%.
Financial StatementsNews
The five best-performing ASX 200 stocks this financial year
Healthcare software developer Pro Medicus narrowly bested family monitoring app Life360 to be the top-performing stock, with a 118.7 per cent return in 12 months.
The ASX business so good ‘you can’t put a sell on it’
Analysts say Pro Medicus is one of the world’s most expensive stocks, but also one of the best.
Why Paradice is backing Seven Group’s bid for Boral
Mid cap investor Jovana Gagic says Kerry Stokes’ conglomerate has a good track record in buying controlling stakes, and reveals why she’s bullish on Orica and Pro Medicus.
ASX PME:
A $2.8 million share buyback helped restore $1.2 billion of value to Pro Medicus, and bulls think the stock – which is already trading at a sky-high multiple – has further to run.
Pro Medicus reports 1H results
The Aussies hoping to make a fortune from Apple’s Vision Pro
The $11 billion ASX software giant Pro Medicus and a Melbourne start-up are among the businesses hoping to cash in on Apple’s new $5000 headset.
Pro Medicus founders in $176m selldown; Unified Capital nabs trade
Fund managers sources said Anthony Hall and Sam Hupert had stockbroker Unified Capital Partners seeking buyers for 2 million shares at $88 apiece.